Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. März 2010 16:30 ET | Quelle: MediciNova, Inc.

MediciNova Reports Positive Preliminary Results From a Phase Ib Clinical Trial of MN-221 in Moderate to Severe COPD Patients

SAN DIEGO, March 17, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
01. Februar 2010 06:00 ET | Quelle: MediciNova, Inc.

MediciNova Appoints Dr. Kirk Johnson Chief Scientific Officer

SAN DIEGO, Feb. 1, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
05. Januar 2010 06:00 ET | Quelle: MediciNova, Inc.

MediciNova Extends Conversion Deadline to January 11, 2010

SAN DIEGO, Jan. 5, 2010 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
18. Dezember 2009 21:00 ET | Quelle: MediciNova, Inc.

MediciNova Completes Acquisition of Avigen

SAN DIEGO, Dec. 18, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
17. Dezember 2009 19:40 ET | Quelle: MediciNova, Inc.

MediciNova and Avigen Stockholders Approve Merger

SAN DIEGO and ALAMEDA, Calif., Dec. 17, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market...
15. Dezember 2009 06:00 ET | Quelle: MediciNova, Inc.

MediciNova and Avigen Confirm Stockholder Election Deadline

SAN DIEGO and ALAMEDA, Calif., Dec. 15, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market...
09. Dezember 2009 17:00 ET | Quelle: MediciNova, Inc.

MediciNova and Avigen Announce Stockholder Election Deadline and Update to Estimated Merger Consideration

SAN DIEGO and ALAMEDA, Calif., Dec. 9, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market...
12. November 2009 17:10 ET | Quelle: MediciNova, Inc.

MediciNova Reports Third Quarter 2009 Results

SAN DIEGO, Calif., Nov. 12, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the...
03. November 2009 18:03 ET | Quelle: MediciNova, Inc.

MediciNova Announces Initiation of a Phase Ib Clinical Trial for MN-221 in Patients With Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease

SAN DIEGO, Nov. 3, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...
16. September 2009 06:00 ET | Quelle: MediciNova, Inc.

MediciNova, Inc. Appoints Mr. Hiroaki Shigeta to Its Board of Directors

SAN DIEGO, Sept. 16, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...

Vorherige Seite